RunaPharma
ActiveSummary
RunaPharma has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€18,060) and a net result of -€1,293. Equity is shrinking by about 8.3% per year across the filed financial years. Its solvency ranks better than 5% of 2,799 sector peers (NACE 82, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Directors
Directors
1 director, last change in 2024
Van der Auwera Lodewijk
CurrentDirector (not named in the articles) · since 15-03-2024
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
1 of this company's 2 Belgian Official Gazette deeds has not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.
Mandate history
1 person since 2024, 1 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| Van der Auwera Lodewijk |
|
Owners and capital
Capital and shareholders
Capital over the years
- 15-03-2024 Converted to unavailable equity · €20,000